go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Delaware rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Professionalmedian $562,341 · 10th to 90th $562,341 to $676,083
$100.0K$200.0K$500.0K$1.0M$2.0Mprofessional $562,341

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$512,861.38
Typical High
$891,250.94